IMA

ImageneBio, Inc.

Nasdaq · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1835579) · 11 signals · 0 setups · updated Aug 16, 2026

What the filings say Pressure ▼

The company can sell stock into the market any day at prevailing prices — steady supply.

Radar 68 (elevated attention) · dilution pressure high · listing risk low · governance risk elevated · runway 33.8 mo · strongest signal: Departure cluster (Jul 23, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

68Radar · attention score (0–100)

76Dilution pressure · financing + balance sheet

0Listing risk · exchange standards

67Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on IMA

Alerts

One email the morning IMA files anything that matches your rules (types, minimum score, setups).

12-month history

Every signal and setup for IMA back a year, not just 30 days — see how the current setup built.

Full analyst notes

What we noticed, evidence with links, what could prove us wrong, red-team caveats.

Full screener + CSV

All 985 flagged companies, same-day, sortable and exportable.

Get Pro · $18.85/mo founding rate See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$94.7Mcash + short-term investments as of Jun 30, 2026

33.8 moestimated runway (annualized 180-day YTD operating cash flow [companyfacts])

$142.1Mstockholders' equity as of Jun 30, 2026

$41.7Mpublic float (10-K cover)

11.4Mshares outstanding as of Jul 31, 2026 · was 11.3M Apr 30, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

Date	Signal	Evidence	Score
Aug 11, 2026	▼ Shelf effective	EFFECT notice 2026-08-11 filing	21
Aug 11, 2026	▼ Shelf effective	EFFECT notice 2026-08-11 filing	21
Aug 6, 2026	▼ Shelf effective	EFFECT notice 2026-08-06 filing	21
Aug 5, 2026	▼ Shelf filed	S-3 filed 2026-08-05 filing	35
Aug 5, 2026	▼ Shelf filed	S-3 filed 2026-08-05 filing	35
Aug 5, 2026	▼ ATM program	“atm” language in S-3 (S-3) filed 2026-08-05 filing	34
Aug 5, 2026	▼ Offering (424B)	424B3 prospectus supplement 2026-08-05; 11 prior 424B filings in 12m filing	28
Jul 23, 2026	▼ Departure cluster	3 Item 5.02 8-Ks in 90 days (latest 2026-07-23) filing	60
Jul 23, 2026	▼ Offering (424B)	424B3 prospectus supplement 2026-07-23; 10 prior 424B filings in 12m filing	28
Jul 23, 2026	· Officer/director change	8-K Item 5.02 filed 2026-07-23 (accepted 16:25 ET) filing	22
Jul 17, 2026	▼ Insider selling before raise	1 insider open-market sale(s) in the 45 days before financing filing on 2026-07-23: Lally Robert B 1,[email protected] 2026-07-17 filing	47

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans